Letter by Lozano et al regarding article, "Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent)"

Circ Cardiovasc Interv. 2010 Oct;3(5):e24; author reply e25. doi: 10.1161/CIRCINTERVENTIONS.110.958355.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Clopidogrel
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / therapy*
  • Drug-Eluting Stents / statistics & numerical data*
  • Humans
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / mortality
  • Myocardial Infarction / therapy*
  • Postoperative Hemorrhage / etiology*
  • Postoperative Hemorrhage / prevention & control
  • Prosthesis Implantation / adverse effects*
  • Risk Factors
  • Survival Analysis
  • Ticlopidine / administration & dosage
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives
  • Withholding Treatment

Substances

  • Clopidogrel
  • Ticlopidine